Basic Research in Infection Biology
Infection Biology Research Areas at Swiss TP
We strive towards acquiring new scientific knowledge in the fields of
- pathogen virulence, survival and transmission;
- infection dynamics and pathogenesis;
- innate and adaptive immunity;
- mechanisms and evolution of drug resistance; and
- pathogen diversity, evolution and population structure.
Our researchers and students employ state-of-the-art methodology nested in the fields of molecular biology, cell biology, biochemistry, in vitro cell culture, immunology, microbiology, genetics, population biology and bioinformatics.
Infectious Diseases in Focus at Swiss TPH
Our Research Units in the Department of Medical Parasitology and Infection Biology conduct cutting-edge basic research on infectious diseases of poverty including
- Malaria (caused by Plasmodium spp.),
- Tuberculosis (caused by Mycobacterium tuberculosis),
- Buruli ulcer (caused by Mycobacterium ulcerans) and
- Sleeping sickness, African trypanosomiasis (caused by Trypanosoma brucei).
Malaria and tuberculosis are two of the most devastating infectious diseases worldwide causing hundreds of millions of clinical cases each year. Buruli ulcer and African trypanosmiasis are so-called neglected tropical diseases that affect the poorest communities.
Malaria is caused by unicellular parasites of the genus Plasmodium that are transmitted from human to human by mosquitoes. P. falciparum is accountable for the majority of severe and fatal malaria cases. P. falciparum blood stage parasites are our main study objects. We explore various crucial aspects of the biology of these intracellular parasites such as red blood cell invasion and remodeling pathways, antigenic variation or sexual differentiation. We are furthermore interested in understanding anti-parasite immunity in malaria pre-exposed populations and the mode-of-action of select anti-malarial drugs.
Human African Trypanosomiasis (also known as sleeping sickness) is caused by the flagellated unicellular parasites of the species Trypanosoma brucei, which are transmitted via tsetse flies in several countries in sub-Saharan Africa. In humans, T. brucei multiplies extracellularly in the blood stream and lymphatic system, known as the first stage of the infection. The second stage of the infection, initiated by parasites crossing the blood-brain barrier, causes severe neurological complications and is fatal if untreated. We investigate the molecular mechanisms of drug resistance in T. brucei combining genetic and bioinformatic approaches.